Trial Site Detail
Drug: |
Regorafenib (BAY 73-4506) |
|||
|---|---|---|---|---|
Trial: |
Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST) (GRID) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Virginia Piper Cancer Center10460 N. 92nd St. |
Principal Investigator: |
Dr. Gordon |
|---|---|
Contact: |
Patient Care Coordinator at 480-323-1339 (toll free: 1-877-273-3713), or e-mail clinicaltrials@shc.org. |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Virginia Piper Cancer Center Website: |
http://www.shc.org/Medical+Services/Cancer+Care/Cancer+Care |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.